Trials / Completed
CompletedNCT02221869
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Jazz Pharmaceuticals · Industry
- Sex
- All
- Age
- 7 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess the efficacy and safety of Xyrem in pediatrics subjects with narcolepsy that includes cataplexy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xyrem |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-02-01
- Completion
- 2019-01-25
- First posted
- 2014-08-21
- Last updated
- 2019-04-30
- Results posted
- 2019-04-30
Locations
20 sites across 4 countries: United States, France, Italy, Netherlands
Source: ClinicalTrials.gov record NCT02221869. Inclusion in this directory is not an endorsement.